Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引:6
|
作者
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
关键词
SCHIZOPHRENIA; INJECTIONS;
D O I
10.1097/JCP.0000000000000610
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:744 / 745
页数:2
相关论文
共 50 条
  • [31] A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
    Pandina, Gahan
    Lane, Rosanne
    Gopal, Srihari
    Gassmann-Mayer, Cristiana
    Hough, David
    Remmerie, Bart
    Simpson, George
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (01): : 218 - 226
  • [32] RISPERIDONE LONG-ACTING INJECTABLE (RLAI) ADMINISTRATION IN DELTOID MUSCLE ... REALLY IS AN IMPROVEMENT?
    Arques, S.
    Arnau, F.
    Rubio, T.
    Pino, A.
    Iranzo, C.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [33] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [34] Paliperidone palmitate long-acting injectable delays psychotic and mood symptom relapse in schizoaffective disorder
    Fu, D. J.
    Alphs, L.
    Lindenmayer, J. P.
    Schooler, N.
    Simonson, R. B.
    Turkoz, I.
    Walling, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S534 - S535
  • [35] PALIPERIDONE PALMITATE: PLACE IN THERAPY AND PRACTICAL USAGE GUIDELINES FOR A NEW LONG-ACTING INJECTABLE ANTIPSYCHOTIC
    Newton, Richard
    Damodaran, Saji
    Hustig, Harry
    Lakshmana, Raju
    Lee, Joseph
    Motamarri, Balaji
    Norrie, Peter
    Parker, Robert
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 : A46 - A46
  • [36] A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
    Henry A Nasrallah
    Srihari Gopal
    Cristiana Gassmann-Mayer
    Jorge A Quiroz
    Pilar Lim
    Mariëlle Eerdekens
    Eric Yuen
    David Hough
    Neuropsychopharmacology, 2010, 35 : 2072 - 2082
  • [37] A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
    Nasrallah, Henry A.
    Gopal, Srihari
    Gassmann-Mayer, Cristiana
    Quiroz, Jorge A.
    Lim, Pilar
    Eerdekens, Marielle
    Yuen, Eric
    Hough, David
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (10) : 2072 - 2082
  • [38] Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate
    Mason, Katy
    Barnett, Joshua
    Pappa, Sofia
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [39] Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
    Kamei, Hiroyuki
    Homma, Yuki
    Takeuchi, Ippei
    Hajitsu, Genta
    Tozawa, Kaori
    Hatano, Masakazu
    Fukui, Aiko
    Hanya, Manako
    Yamada, Shigeki
    Iwata, Nakao
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2020, 18 (01) : 49 - 57
  • [40] Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
    Alphs, Larry
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Ma, Yi-Wen
    Sliwa, Jennifer Kern
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1029 - 1042